Form 4 for DGX Quest Diagnostics
Accepted 2024-11-07 00:00:00 ET · period of report 2024-11-06 · accession 0001022079-24-000204 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-07 | 2024-11-06 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | M - OptEx | $68.66 | +18.8K | 43.6K | +76% | +$1.29M |
| DM | 2024-11-07 | 2024-11-06 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | S - Sale+OE | $154.04 | -18.8K | 34.9K | -35% | -$2.89M |
| DM | 2024-11-07 | 2024-11-06 | DGX | DEPPE MICHAEL J | SVP, CAO, Corp. Ctrl | M - OptEx | $68.66 | -18.8K | 0 | -100% | -$1.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | M | A | 10,120 | $66.51 | 53,696 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-06 | S | D | 2,100 | $152.70 | 51,596 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $152.400 to $153.200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-11-06 | M | A | 8,635 | $71.17 | 43,576 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-06 | S | D | 2,400 | $153.98 | 49,196 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2024-11-06 | S | D | 4,135 | $154.74 | 45,061 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $154.460 to $155.180. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2024-11-06 | S | D | 2,600 | $152.71 | 42,461 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $152.400 to $153.170. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2024-11-06 | S | D | 2,331 | $154.03 | 40,130 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2024-11-06 | S | D | 5,189 | $154.74 | 34,941 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $154.460 - $155.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F7) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |
| 9 | Derivative | Non-Qualifed Stock Option (right to buy) | 2024-11-06 | M | D | 8,635 | $71.17 | 0 | D | $71.17 · — to 2025-02-23 | 8,635 Common Stock | (F9) The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. |
| 10 | Derivative | Non-Qualifed Stock Option (right to buy) | 2024-11-06 | M | D | 10,120 | $66.51 | 0 | D | $66.51 · — to 2026-02-25 | 10,120 Common Stock | (F10) The options vested in three annual installments beginning with the first on February 26, 2017, the second on February 25, 2018 and the final on February 25, 2019. |